MR编号 | SE/H/0481/002 |
---|
药品名称 | Fosrenol |
---|
活性成分 | - lanthanum(III)carbonate 500.0 mg
|
---|
剂型 | Chewable tablet |
---|
上市许可持有人 | Takeda Pharmaceuticals International AG Ireland Branch |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- Ireland (IE)
- Austria (AT)
Fosrenol 500 mg Kautabletten - France (FR)
- Spain (ES)
- Italy (IT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Latvia (LV)
Fosrenol 500 mg košļājamās tabletes - Estonia (EE)
FOSRENOL - Hungary (HU)
FOSRENOL 500 mg rágótabletta - Bulgaria (BG)
Fosrenol - Cyprus (CY)
- Czechia (CZ)
- Slovakia (SK)
Fosrenol 500 mg žuvacie tablety - Slovenia (SI)
- Malta (MT)
- Lithuania (LT)
FOSRENOL 500 mg kramtomosios tabletės
|
---|
许可日期 | 2005/03/01 |
---|
最近更新日期 | 2024/07/18 |
---|
药物ATC编码 | - V03AE03 lanthanum carbonate
|
---|
申请类型 | - TypeLevel1:New Active Substance
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Full Dossier [Article 8.3(i)]
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|